Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $108,875 (100.0% shares, 0.0% debt)

Holdings (12)

REPL Replimune Group 47.2%

Value ($000) $51,353 Shares 3,001,319 Est. Cost $17.40 Unrealized +12.9%

NUVB Nuvation Bio 18.6%

Value ($000) $20,197 Shares 15,072,340 Est. Cost $11.18 Unrealized -85.1%

— Ikena Oncology 8.9%

Value ($000) $9,739 Shares 2,249,123 Est. Cost $28.25 Unrealized —

— Morphic Holding 6.5%

Value ($000) $7,099 Shares 309,846 Est. Cost $19.82 Unrealized —

— Kronos Bio 4.6%

Value ($000) $4,964 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Spruce Biosciences 4.5%

Value ($000) $4,884 Shares 2,161,022 Est. Cost $24.31 Unrealized —

SANA Sana Biotechnology, Inc. 3.0%

Value ($000) $3,265 Shares 843,750 Est. Cost $32.56 Unrealized -83.5%

IMUX Immunic Inc 2.4%

Value ($000) $2,629 Shares 1,788,160 Est. Cost $13.89 Unrealized -86.2%

— Theseus Pharmaceuticals 1.8%

Value ($000) $1,914 Shares 711,479 Est. Cost $12.68 Unrealized —

— Alpine Immune Sciences 1.6%

Value ($000) $1,760 Shares 153,700 Est. Cost $9.48 Unrealized —

SYRS Syros Pharmaceuticals 0.9%

Value ($000) $993 Shares 251,270 Est. Cost $8.12 Unrealized -53.9%

— Senti Biosciences, Inc. 0.1%

Value ($000) $81 Shares 195,792 Est. Cost $1.97 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	3,001,319	$51,353	47.2%	$17.40	+12.9%	Common Stock	76029N106
NUVB	Nuvation Bio	15,072,340	$20,197	18.6%	$11.18	-85.1%	Common Stock Class A	67080N101
—	Ikena Oncology	2,249,123	$9,739	8.9%	$28.25	—	Common Stock	45175G108
—	Morphic Holding	309,846	$7,099	6.5%	$19.82	—	Common Stock	61775R105
—	Kronos Bio	3,818,283	$4,964	4.6%	$29.87	—	Common Stock	50107A104
—	Spruce Biosciences	2,161,022	$4,884	4.5%	$24.31	—	Common Stock	85209E109
SANA	Sana Biotechnology, Inc.	843,750	$3,265	3.0%	$32.56	-83.5%	Common Stock	799566104
IMUX	Immunic Inc	1,788,160	$2,629	2.4%	$13.89	-86.2%	Common Stock	4525EP101
—	Theseus Pharmaceuticals	711,479	$1,914	1.8%	$12.68	—	Common Stock	88369M101
—	Alpine Immune Sciences	153,700	$1,760	1.6%	$9.48	—	Common Stock	02083G100
SYRS	Syros Pharmaceuticals	251,270	$993	0.9%	$8.12	-53.9%	Common Stock	87184Q206
—	Senti Biosciences, Inc.	195,792	$81	0.1%	$1.97	—	Common Stock	81726A100